Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 803 of 6351
-
New drug aficamten shows promise for thick heart muscle in chinese patients
Disease control CompletedThis is an open-label extension study of China cohort in the phase 3 study (CY 6031) of aficamten for the treatment of obstructive HCM (oHCM) to collect long-term safety and tolerability data, including assessments of cardiac function and steady-state Pharmacokinetics (PK) during…
Phase 3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Botox for jaw pain: a shot at rewiring pain signals?
Disease control Recruiting nowThe goal of this clinical trial is to investigate the effect of botulinum toxin on neurons' plasticity in the masseter muscle in humans with and without painful myogenous temporomandibular disorders (TMDM). The main questions it aims to answer are: * does treatment with botulinu…
Phase 2 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Supercharged CAR t cells take on tough lymphoma
Disease control OngoingThis is a Phase I, open-label dose finding study to assess the safety and feasibility, pharmacokinetics, and preliminary efficacy of TmCD19-IL18 CAR T cells in patients with CD19+ cancers. This study will take place in two parts: a Dose-Finding Phase to determine the maximum tole…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental CAR t therapy takes on solid tumors in first human trial
Disease control Recruiting nowThis is a dose-escalation open-label Phase 1/2a study. The purpose of this first-in-human study is to assess the safety and tolerability of LEU011 (autologous CAR T cells targeting NKG2D ligands) in patients with solid tumours.
Phase 1/2 • Sponsor: Leucid Bio • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New cell therapy aims to tame deadly transplant complication in kids
Disease control OngoingThe purpose of this trial is the comparative evaluation of overall response rate (ORR) in paediatric participants with steroid-refractory acute graft-versus-host disease (SR-aGvHD) at Visit Day 28 after treatment with MC0518 or first used best available therapy (BAT).
Phase 2 • Sponsor: medac GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
RNA vaccine takes on malaria: early trial shows promise
Vaccine CompletedThis was a randomized, dose-escalation Phase I/IIa study to evaluate safety, tolerability, immunogenicity and efficacy of an investigational RNA-based vaccine (BNT165e) for prevention of P. falciparum malaria in healthy malaria-naive adults. The multi-antigen malaria vaccine (de…
Phase 1/2 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Aug 30, 2026 00:00 UTC
-
New hope for young transplant patients: maribavir trial targets CMV
Disease control Recruiting nowThe main aim of this study is to find out the safety, tolerability and pharmacokinetics (PK) of maribavir for the treatment of CMV infection in children and teenagers after HSCT or SOT and to identify the optimal dose of maribavir using a 200 milligrams (mg) tablet formulation or…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug cocktail shows promise in battling advanced head and neck cancer
Disease control OngoingMulti-center, open-label, non-randomized, non-comparative two-cohort study for patients with locally-advanced squamous cell carcinoma arising from the larynx, hypopharynx, oropharynx (Stage III, IVA and IVB according to 8th TNM/AJCC ed.) and oral cavity (unresectable, stage IVB a…
Phase 1/2 • Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
A digital lifeline for dementia caregivers: can Self-Care modules ease the burden?
Symptom relief CompletedIn the US, the over 11 million Americans currently providing unpaid care to a family member, relative, or friend with Alzheimer's disease or a related dementia (ADRD) are over 6 times more likely than the general population to suffer from depression (33.9% vs. 5%), and nearly 60%…
Sponsor: Pro-Change Behavior Systems • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
A portable sleep test could unmask hidden sleep apnea in millions with high blood pressure
Diagnosis OngoingUncontrolled hypertension is associated with an increased risk of heart disease, stroke, and mortality. Obstructive sleep apnea (OSA) is common in hypertension and treatment using continuous positive airway pressure (CPAP) has been shown to effectively lower blood pressure. Despi…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New combo aims to shrink Hard-to-Treat colon tumors
Disease control OngoingCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is given in combination with Fluorouracil, Folinic Acid, and Bevacizumab to adult par…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Which vaccine schedule keeps children protected longest?
Prevention OngoingThe main objective of this study is to evaluate the persistence of Japanese encephalitis antibodies in participants at the age of 6, after they have followed different Japanese encephalitis vaccination schedules. Furthermore, the study will assess the immunogenicity and antibody …
Phase 4 • Sponsor: Liaoning Chengda Biotechnology CO., LTD • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Can imagining movement help kids recover arm function after a birth injury?
Disease control CompletedThe aim of this study is to investigate the effect of graded motor imagery training on upper extremity motor function, proprioception, functional mobility, balance and quality of life in patients with obstetric brachial plexus injury in addition to conventional treatment. In this…
Sponsor: Izmir Bakircay University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
A radioactive clue that could spare thousands from thyroid surgery
Diagnosis Stopped earlyThis study evaluates radioiodine planar and SPECT/CT imaging with iodine-123 in patients with follicular thyroid nodules prior to surgery. Because biopsy alone is not sufficient to distinguish between malignant follicular thyroid nodules and benign follicular thyroid nodules, pat…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
New drug efruxifermin aims to reverse liver scarring in NASH patients
Disease control OngoingThe aim of this study is to assess the safety and tolerability of EFX compared to placebo in subjects with non-invasively diagnosed NASH/MASH and NAFLD/MASLD.
Phase 3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Frozen testicle tissue may help men have kids after cancer
Disease control Recruiting nowSpermatogonial stem cell transplantation through ultrasound guided rete testis injection and testicular tissue grafting will be performed for participants who have frozen testicular tissue prior to gonadotoxic therapy. The purpose of this study is to test the safety and feasibili…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for aggressive lung cancer: dual-drug trial launches
Disease control Recruiting nowThis phase II study is designed to investigate the efficacy and safety of BL-B01D1 monotherapy, SI-B003 monotherapy, and BL-B01D1+SI-B003 combination therapy in patients with extensive-stage small cell lung cancer.
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Freezing or heating prostate tumors: a targeted alternative to surgery?
Disease control Recruiting nowThis clinical trial evaluates the effectiveness of focal ablation with either focal cryotherapy or high intensity frequency ultrasound for the treatment of men with localized prostate cancer. Focal cryotherapy kills tumor cells by freezing them. High intensity frequency ultrasoun…
Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Creatine plus resistance training may help prostate cancer patients preserve muscle
Disease control Recruiting nowThe goal of this clinical trial is to test the use of creatine monohydrate supplementation with resistance training to preserve muscle mass and help lessen prostate cancer progression. The main question it aims to answer is if this treatment will help maintain muscle mass to hel…
Phase 3 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New immune cell therapy takes on tough lymphoma
Disease control OngoingThis study will have two Phases: Phase 1a and Phase 1b. The goal of Phase 1a of this clinical study is to learn more about the safety, tolerability and dosing of study drug KITE-197, in participants with relapsed or refractory large B-cell lymphoma (r/rLBCL). The goal of Phase 1b…
Phase 1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC